The Story Behind the Cover Picture
D’Agoty’s early anatomical painting of the liver
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:65
.
(01 June 2026)
Original Article
Impact of metabolic dysfunction-associated steatotic liver disease on long-term prognosis in hepatocellular carcinoma patients undergoing hepatectomy
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:66
.
(01 June 2026)
PDF
Full Text
(184)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
This study reveals that metabolic dysfunction-associated steatotic liver disease (MASLD) is a significant risk factor for poor recurrence-free survival (RFS) and overall survival (OS) in hepatocellular carcinoma (HCC) patients undergoing hepatectomy, emphasizing the importance of preoperative MASLD diagnosis for prognosis guidance.
Enhanced long-term outcomes with laparoscopic bariatric surgery in patients with severe obesity and metabolic dysfunction-associated steatotic liver disease: a retrospective cohort study
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:67
.
(01 June 2026)
In this population-based study, laparoscopic surgery is associated with lower risk of liver and non-liver adverse outcomes, as well as lower healthcare utilization and pharmacy costs in patients with metabolic dysfunction-associated steatotic liver disease and severe obesity as compared to open surgery.
Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter study
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:68
.
(01 June 2026)
A new calculator, the DCDAM score, utilizes diameter, cirrhosis, differentiation, AFP, and MVI grade to accurately predict early recurrence of HCC with MVI. Patients in the high-risk group (DCDAM score > 169) experience poor RFS and OS and respond well to postoperative adjuvant TACE.
Does neoadjuvant therapy reduce pancreatic fistula after pancreatoduodenectomy and distal pancreatectomy?—a systematic review and meta-analysis
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:69
.
(01 June 2026)
This systematic review and meta-analysis found that neoadjuvant therapy significantly reduces the risk of postoperative pancreatic fistula (POPF) after pancreatoduodenectomy, likely due to induced pancreatic fibrosis. It suggests potential for improved surgical outcomes but emphasizes the need for individualized treatment based on predicted tumor response.
Review Article
A systematic review of methodology in nutritional trials in patients undergoing pancreatoduodenectomy
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:70
.
(01 June 2026)
There is evidence of widespread variation in the methodology amongst published trials of nutritional interventions in patients undergoing pancreatoduodenectomy. This makes comparing the effect of these different nutritional interventions on postoperative outcomes difficult and has implications for design of future nutritional trials in this area.
Precision transarterial chemoembolization in hepatocellular carcinoma: patient selection, standardized techniques, and quantitative evaluation
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:71
.
(01 June 2026)
With the aim to enhance quality control and standardize TACE procedures, the concept of "precision TACE" is introduced by ISMIO, emphasizing standardized angiography, superselective catheterization and embolization, appropriate selection of embolic agents, determination of optimal embolization endpoints, and evaluation for efficacy immediately post-TACE.
Expert Consensus
Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition)
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:72
.
(01 June 2026)
This updated 2024 Chinese expert consensus details conversion and perioperative strategies for hepatocellular carcinoma (HCC). It refines definitions and integrates new systemic and locoregional therapies with surgery to downstage tumors for resection. A multidisciplinary collaboration approach is emphasized to improve long-term survival for HCC patients.
French Editorial Commentary from the ACHBPT
Towards omission of drainage in distal pancreatectomy—the PANDRA II study: another brick in the wall!
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:73
.
(01 June 2026)
Editorial Commentary
Liver dysfunction associated with severe acute pancreatitis: molecular mechanisms and clinical insights
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:74
.
(01 June 2026)
Refining the boundaries of resectability for colorectal cancer liver metastases with extrahepatic disease—surgical lessons from a nationwide analysis
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:75
.
(01 June 2026)
Benchmarking performance in robotic liver resection: are we measuring what matters?
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:76
.
(01 June 2026)
Global benchmarks for robotic liver resection: Eastern excellence calls for reevaluation in the West
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:77
.
(01 June 2026)
Revisiting treatment paradigms for colorectal liver metastases: liver transplant or associating liver partition and portal vein ligation for staged hepatectomy?
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:78
.
(01 June 2026)
Pushing to resect colorectal liver metastases: rethinking surgical strategy in colorectal liver metastases with extrahepatic spread
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:79
.
(01 June 2026)
Adjuvant therapy after R0 resection for primary hepatic sarcomatoid carcinoma
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:80
.
(01 June 2026)
Pushing the boundaries of surgical resectability in colorectal liver metastases: the advancing role of two-stage hepatectomy
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:81
.
(01 June 2026)
Transplantation for unresectable perihilar cholangiocarcinoma beyond the Mayo protocol: a challenge for SURE
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:82
.
(01 June 2026)
Outcomes after surgery for locally advanced pancreatic cancer compared to borderline and upfront resectable pancreatic cancer
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:83
.
(01 June 2026)
Advancing risk stratification in intermediate-stage hepatocellular carcinoma undergoing transarterial chemoembolization: the promise of the NTAA model
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:84
.
(01 June 2026)
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) vs. liver transplantation for borderline-resectable colorectal liver metastases: evidence not yet definitive
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:85
.
(01 June 2026)
Hepatocellular carcinoma surveillance—is it time to update clinical practice?
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:86
.
(01 June 2026)
Survival after resection of pancreatic cancer is similar with neoadjuvant gemcitabine-nab-paclitaxel or mFOLFIRINOX but one size will not fit all in the future
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:87
.
(01 June 2026)
Moving the needle on donation after circulatory death procedures
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:88
.
(01 June 2026)
Rethinking nutritional risk in cancer: muscle quality, myosteatosis, and prognosis
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:89
.
(01 June 2026)
Refining prognostication in intermediate-stage hepatocellular carcinoma after transarterial chemoembolization: promise and limitations of the proposed NTAA model
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:90
.
(01 June 2026)
Sex disparity in liver cancer recurrence—from bench to bedside
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:91
.
(01 June 2026)
The evolution of liver graft preservation strategies in liver transplantation
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:92
.
(01 June 2026)
Letter to the Editor
Immune-mediated tumor regression and subsequent escape driven by antigen loss and major histocompatibility complex (MHC) class I downregulation following GPC3 DNA vaccination in hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:93
.
(01 June 2026)
A novel anastomotic technique reducing biliary complications in small-duct reconstruction during adult living donor liver transplantation
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:94
.
(01 June 2026)
Single-port robotic pancreaticoduodenectomy with the SHURUI snake-arm system: first clinical application
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:95
.
(01 June 2026)
Images in Clinical Medicine
Wandering spleen
HepatoBiliary Surgery and Nutrition
2026;
15
(3)
:96
.
(01 June 2026)
